Understanding Immunity in Children Vaccinated With Live Attenuated Influenza Vaccine

被引：12
作者：
Shannon, Ian [1 ]
White, Chantelle L. [2 ]
Nayak, Jennifer L. [1 ]
机构：
[1] Univ Rochester, Med Ctr, Dept Pediat, Div Infect Dis, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA
来源：
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2020年 / 9卷
关键词：
immune protection; influenza; influenza vaccines; LAIV; T-CELL RESPONSES; HEMAGGLUTINATION-INHIBITION; SEASONAL INFLUENZA; UNITED-STATES; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; B-CELL; VIRUS; PROTECTION; TRIVALENT;
D O I：
10.1093/jpids/piz083
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Live attenuated influenza vaccine (LAIV), or FluMist, was approved for use in the United States in 2003. This vaccine, administered intranasally, offers the advantage of stimulating immunity at the site of infection in the upper respiratory tract and, by mimicking natural infection, has the potential to elicit a multifaceted immune response. However, the development of immunity following LAIV administration requires viral replication, causing vaccine effectiveness to be impacted by both the replicative fitness of the attenuated viruses being administered and the degree of the host's preexisting immunity. In this review, we discuss the current state of knowledge regarding the mechanisms of protection elicited by LAIV in children, contrast this with immune protection that develops upon vaccination with inactivated influenza vaccines, and briefly discuss both the potential advantages as well as challenges offered by this vaccination platform.
引用
收藏
页码：S10 / S14
页数：5
相关论文
共 50 条
  • [31] Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults
    Hoft, Daniel F.
    Lottenbach, Kathleen R.
    Blazevic, Azra
    Turan, Aldin
    Blevins, Tamara P.
    Pacatte, Thomas P.
    Yu, Yinyi
    Mitchell, Michelle C.
    Hoft, Stella G.
    Belshe, Robert B.
    CLINICAL AND VACCINE IMMUNOLOGY, 2017, 24 (01)
  • [32] Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States
    Caspard, Herve
    Gaglani, Manjusha
    Clipper, Lydia
    Belongia, Edward A.
    McLean, Huong Q.
    Griffin, Marie R.
    Talbot, H. Keipp
    Poehling, Katherine A.
    Peters, Timothy R.
    Veney, Naomi
    Ambrose, Christopher S.
    VACCINE, 2016, 34 (01) : 77 - 82
  • [33] Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age
    Belshe, Robert B.
    Toback, Seth L.
    Yi, Tingting
    Ambrose, Christopher S.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2010, 4 (03) : 141 - 145
  • [34] Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity
    Roy, Sreeja
    Williams, Clare M.
    Pardo, Julian
    Wijesundara, Danushka K.
    Furuya, Yoichi
    VACCINES, 2020, 8 (03) : 1 - 6
  • [35] Influenza vaccination rates in children decline when the live attenuated influenza vaccine is not recommended
    Fogel, Benjamin
    Hicks, Steven
    VACCINE, 2017, 35 (39) : 5278 - 5282
  • [36] The safety of live attenuated influenza vaccine in children and adolescents 2 through 17years of age: A Vaccine Safety Datalink study
    Daley, Matthew F.
    Clarke, Christina L.
    Glanz, Jason M.
    Xu, Stanley
    Hambidge, Simon J.
    Donahue, James G.
    Nordin, James D.
    Klein, Nicola P.
    Jacobsen, Steven J.
    Naleway, Allison L.
    Jackson, Michael L.
    Lee, Grace
    Duffy, Jonathan
    Weintraub, Eric
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (01) : 59 - 68
  • [37] Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women
    Brady, Rebecca C.
    Jackson, Lisa A.
    Frey, Sharon E.
    Shane, Andi L.
    Walter, Emmanuel B.
    Swamy, Geeta K.
    Schlaudecker, Elizabeth P.
    Szefer, Elena
    Wolff, Mark
    McNeal, Monica Malone
    Bernstein, David I.
    Steinhoff, Mark C.
    VACCINE, 2018, 36 (31) : 4663 - 4671
  • [38] Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine
    Wan, Zhimin
    Garcia, Stivalis Cardenas
    Liu, Jing
    Santos, Jefferson
    Carnaccini, Silvia
    Geiger, Ginger
    Ferreri, Lucas
    Rajao, Daniela
    Perez, Daniel R.
    JOURNAL OF VIROLOGY, 2018, 92 (21)
  • [39] Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma
    Nordin, James D.
    Vazquez-Benitez, Gabriela
    Olsen, Avalow
    Kuckler, Leslie C.
    Gao, Ashley Y.
    Kharbanda, Elyse O.
    VACCINE, 2019, 37 (30) : 4055 - 4060
  • [40] Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity
    Ambrose, Christopher S.
    Wu, Xionghua
    Caspard, Herve
    Belshe, Robert B.
    VACCINE, 2014, 32 (43) : 5546 - 5548
12345